A detailed history of Creative Planning transactions in Abeona Therapeutics Inc. stock. As of the latest transaction made, Creative Planning holds 15,005 shares of ABEO stock, worth $63,621. This represents 0.0% of its overall portfolio holdings.

Number of Shares
15,005
Holding current value
$63,621
% of portfolio
0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024

BUY
$4.07 - $8.68 $61,070 - $130,243
15,005 New
15,005 $108,000
Q3 2023

Nov 16, 2023

BUY
$2.98 - $4.43 $41,734 - $62,042
14,005 New
14,005 $58,000
Q1 2023

May 15, 2023

BUY
$2.25 - $3.27 $4,500 - $6,540
2,000 Added 9.99%
22,011 $62,000
Q4 2022

Feb 10, 2023

BUY
$2.4 - $4.39 $48,026 - $87,848
20,011 New
20,011 $61,000

Others Institutions Holding ABEO

About ABEONA THERAPEUTICS INC.


  • Ticker ABEO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 5,950,380
  • Market Cap $25.2M
  • Description
  • Abeona Therapeutics Inc., a clinical-stage biopharmaceutical company, develops gene and cell therapies for life-threatening rare genetic diseases. Its lead program is EB-101, an autologous, gene-corrected cell therapy that is in Phase III clinical trial for recessive dystrophic epidermolysis bullosa. The company also develops ABO-102, an adeno-a...
More about ABEO
Track This Portfolio

Track Creative Planning Portfolio

Follow Creative Planning and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Creative Planning, based on Form 13F filings with the SEC.

News

Stay updated on Creative Planning with notifications on news.